AI Summary Overview
What is Muscular Dystrophy?
Muscular dystrophy (MD) is a set of genetic disorders that slowly weaken skeletal muscles. Gene mutations disrupt the proteins needed to maintain healthy muscle fibres, causing them to become damaged and gradually replaced by fatty and connective tissue. This progressive muscle loss can make movement and everyday activities increasingly difficult.
The different types of MD can develop at different ages, from infancy and childhood to adolescence and adulthood, depending on the specific genetic disorder.
What are the Types of Muscular Dystrophy?
The prevalence and severity of muscular dystrophy depend on the specific type of the disease affecting an individual. It includes:
-
Duchenne Muscular Dystrophy Duchenne muscular dystrophy is the most common and severe type, which is usually present from birth. Doctors and parents typically identify it when the child (young boys) is between 3 and 5 years old. It is caused by a mutation of the gene responsible for producing dystrophin. The disease causes the leg and pelvic muscles to weaken first, eventually spreading to the entire body.
-
Becker Muscular Dystrophy Becker muscular dystrophy is pretty similar to Duchenne but relatively milder. Males with this condition typically do not show symptoms until their teen years or early adulthood. Many can stay mobile for much longer compared to those with Duchenne.
-
Myotonic Dystrophy Myotonic dystrophy is characterised by myotonia, which is an inability of the muscles to relax after contraction (such as difficulty releasing a handshake). Unlike forms that mainly impact skeletal, cardiac, and respiratory systems, it causes distinct multisystem complications, including early-onset cataracts, endocrine issues, and cardiac conduction abnormalities. Consequently, it requires multidisciplinary management.
-
Limb-Girdle Muscular Dystrophy In limb-girdle muscular dystrophy, muscle weakness usually begins around the hips and shoulders. Symptoms often appear during adolescence or adulthood and may progress at different rates. Physiotherapy can help maintain mobility, strength and flexibility, whereas heart and lung monitoring becomes crucial to avoid any heart complications.
-
Facioscapulohumeral Muscular Dystrophy Facioscapulohumeral muscular dystrophy primarily affects the muscles of the face, shoulder blades and upper arms. Symptoms commonly begin during adolescence or young adulthood. Some people may also develop weakness in the lower legs, hearing problems or eye-related complications.
-
Congenital Muscular Dystrophy Congenital muscular dystrophy is present from birth. It commonly causes weakness in the neck, upper arms and legs, and some children may have reduced muscle tone or delayed motor development. Certain forms can also affect the brain, heart, lungs or spine.
-
Distal Muscular Dystrophy Distal muscular dystrophy mainly affects muscles farther from the centre of the body, particularly the hands, feet, lower arms and lower legs. Symptoms generally begin in adulthood (often between 40 and 60 years) and may progress slowly. Some forms can also involve the heart.
-
Oculopharyngeal Muscular Dystrophy Oculopharyngeal muscular dystrophy usually develops after the age of 40. It mainly affects the muscles controlling the eyelids and swallowing, which can cause drooping eyelids and difficulty swallowing. Weakness may later involve the shoulders, hips and upper legs.
-
Emery-Dreifuss Muscular Dystrophy Emery-Dreifuss muscular dystrophy usually begins during childhood. It can cause weakness in the upper arms and lower legs, along with stiffness or contractures around the elbows, ankles and neck. Heart involvement is an important feature and may cause abnormal heart rhythms that require regular monitoring.
How Common is Muscular Dystrophy in India?
Muscular dystrophy is a significant health concern in India. The condition includes several types, but Duchenne muscular dystrophy (DMD) is the most common childhood inherited muscle disease in the country. It primarily affects boys and causes progressive muscle weakness, with symptoms often appearing in early childhood.
Based on a global prevalence of 7.1 cases per 1,00,000 males, more than 51,402 people in India are estimated to have DMD. Congenital muscular dystrophy (CMD) is much rarer, with a reported prevalence of around 0.6 to 0.9 per 1,00,000 live births.
What are the Symptoms of Muscular Dystrophy?
Symptoms of muscular dystrophy vary depending on the type and severity of the condition. Some of the common early warning signs and advanced stage symptoms are listed below:
| Early Warning Signs | Advanced Stage Symptoms |
|
|
What Causes Muscular Dystrophy?
Since muscular dystrophy is an inherited disorder, it is caused mainly by a defect in the genes. These changes impair the production of vital proteins that muscles need to stay healthy and strong.
The main causes of muscular dystrophy are as follows:
-
X-linked Inheritance: Many forms, including Duchenne and Becker muscular dystrophy, are X-linked. Since males have one X chromosome, inheriting the faulty gene usually causes the condition, while females with a second healthy copy are typically asymptomatic carriers who can pass it to their children.
-
Autosomal Dominant Inheritance: For other kinds of muscular dystrophy, there is autosomal dominant inheritance. People only need to inherit one copy of the faulty gene from an affected parent to have muscular dystrophy.
-
Autosomal Recessive Inheritance: Sometimes, a child can get abnormal genes from both parents. The parents may be unaffected carriers if it is in a recessive form. These children may develop the disorder if they inherit abnormal copies of the gene from both parents.
-
Spontaneous (De Novo) Mutations: A new genetic change can arise spontaneously in an egg, sperm or during early development. In these cases, muscular dystrophy may occur even when there is no previous family history of the condition.
Stages of Muscular Dystrophy
Muscular dystrophy does not have a single fixed staging system because progression varies considerably across types. In general, the condition may progress from mild muscle weakness to increasing loss of mobility and, in some forms, heart or breathing complications.
The progression stages of muscular dystrophy are described briefly in the table below:
| Progression Stage | Typical Features |
| Early Ambulatory Stage | Usually begins in early childhood. Delayed motor milestones, muscle weakness, frequent falls, difficulty getting up from a seated or floor position, toe walking and an unsteady gait may develop. |
| Late Ambulatory Stage | Muscle weakness becomes more noticeable, particularly in the legs and trunk. Walking becomes increasingly difficult, and braces or other mobility aids may be needed. Contractures, weak bones and scoliosis may also develop. |
| Non-Ambulatory Stage | Independent walking is lost, and a wheelchair is generally required for mobility. Weakness may progressively affect the arms, breathing muscles and heart, increasing the risk of respiratory and cardiac complications. |
Diseases Similar to Muscular Dystrophy
Muscular dystrophy may resemble other conditions that cause progressive muscle weakness, difficulty walking, or movement problems. Spinal muscular atrophy (SMA) and myasthenia gravis are diseases that can cause similar symptoms but affect the nerves and muscles in different ways.
A comparative overview of the three conditions is provided below:
Muscular Dystrophy Vs. Spinal Muscular Atrophy Vs. Myasthenia Gravis
| Feature | Muscular Dystrophy | Spinal Muscular Atrophy (SMA) | Myasthenia Gravis |
| How It Happens | Genetic changes interfere with proteins needed for healthy muscle, causing progressive muscle weakness and wasting. | Genetic changes damage motor neurons that control skeletal muscles, leading to muscle weakness and wasting. | An autoimmune reaction disrupts communication between nerves and muscles, causing muscles to weaken easily. |
| Location | Mainly affects skeletal muscles, although some types may also involve the heart and respiratory muscles. | Affects motor neurons in the spinal cord and brainstem, resulting in weakness of muscles throughout the body. | Commonly affects the eye, face, throat, neck and limb muscles and may also affect breathing muscles. |
| Associated Symptoms | Progressive weakness, frequent falls, difficulty walking, muscle wasting, contractures, and sometimes breathing or heart problems may occur. | Muscle weakness, reduced muscle tone, movement difficulties, twitching and problems with swallowing or breathing may occur. | Drooping eyelids, double vision, and difficulty chewing or swallowing. Characterised by fluctuating muscle weakness that worsens with activity and improves significantly with rest. |
| Severity | Severity and progression vary considerably between different types of muscular dystrophy. | Severity varies by type and age of onset, with some forms causing significant breathing and mobility problems. | Symptoms may range from mild weakness to severe swallowing or breathing problems during a myasthenic crisis. |
| Can It Be Reversed? | There is currently no cure, but treatment can manage symptoms and slow progression in some types. | There is no complete cure, but disease-modifying treatments can improve motor function and slow progression. | Treatment can control symptoms effectively, and some patients experience periods of remission, although the condition is usually long-term. |
What are the Complications of Muscular Dystrophy?
If left untreated, muscular dystrophy may cause the following complications that require immediate attention:
-
Mobility Loss: Progressive muscle weakness can make walking and other movements increasingly difficult. As muscle strength declines, some patients may eventually require a wheelchair for mobility. Prolonged muscle weakness and inactivity can also lead to muscle contractures and deformities.
-
Breathing Disorders: The patient's lungs become weak due to a lack of muscle strength. TThis results in an inability to cough and clear the airway, leading to infections such as pneumonia.
-
Heart Disorders: Heart muscle damage could result in cardiomyopathy, abnormal heart rhythms and heart failure. This is especially prevalent in conditions like Duchenne muscular dystrophy and Becker muscular dystrophy.
-
Skeletal Abnormalities: Weakness in the back and other supporting muscles can cause spinal curvature, poor posture and foot problems. Progressive muscle shortening may also lead to contractures, restricting joint movement and further affecting mobility.
-
Dysphagia and Nutritional Issues: Weakness of the throat and facial muscles may lead to difficulty in swallowing, aspiration and malnutrition.
-
Difficulty Speaking:Speech difficulties can result from muscle weakness in the facial, mouth, tongue, and throat muscles.
-
Digestive Problems: Difficulty in passing stools due to lack of exercise and muscle weakness in the abdomen. Delayed gastric emptying and other digestive problems depend on the MD type.
-
Psychiatric Problems: Includes anxiety, depression, poor body image and feelings of isolation due to long-standing MD.
-
Increased Risk of Infection: Includes respiratory infections because of weak cough reflexes.
When Should I See My Healthcare Provider?
Consult a physician if you notice the following muscular dystrophy symptoms:
-
Delay in walking
-
Frequently falling
-
Weakness or trouble climbing stairs
-
Trouble getting up from sitting on the floor
-
Walking on toes or having unusually enlarged calf muscles
-
Difficulty raising arms overhead or carrying objects
-
Muscle stiffness, cramping, or an inability to relax a hand grip
-
New speech delays, drooping eyelids, or difficulty swallowing
-
Having relatives with muscular dystrophy
How is Muscular Dystrophy Diagnosed?
Muscular dystrophy is often diagnosed through genetic testing. The following tests may also be recommended to assess muscle function and identify signs of muscle damage:
| Test Name | What It Detects | Purpose |
| Creatine Kinase (CK) Blood Test | Registers at 10 to 100 times higher than normal for Duchenne Muscular Dystrophy | Shows muscle damage. Usually, the first test used to spot initial issues. |
| Genetic testing | Mutations in genes like the dystrophin gene | Confirms the diagnosis and pinpoints the exact type of muscular dystrophy |
| Electromyography (EMG) | Abnormal muscle or nerves activity | Picks up abnormal muscle activity patterns |
| Muscle biopsy | Signs like degeneration, scarring or missing muscle proteins | To identify characteristic MD features in muscle tissues |
| MRI | Wasted muscles and areas where fat has taken over muscle tissue | Show which muscles have been affected the most and track how the disease progresses over time |
Note: Genetic tests confirm most cases of muscular dystrophy. When doctors find high creatine kinase levels, that often suggests the issue. Heart and lung exams assist in spotting complications and devising ongoing care plans.
How is Muscular Dystrophy Treated?
As muscular dystrophy is a genetic condition, it cannot be cured. However, treatment and supportive measures can help manage symptoms, maintain muscle function and prevent complications:
-
Physical Therapy: Regular physiotherapy helps to improve flexibility, mobility and muscle function, lowering the risk of contractures.
-
Mobility Devices: Braces, walkers and wheelchairs improve independence and safety as well.
-
Breathing Support: Weak muscles can make breathing tough, but breathing exercises may help improve breathing
-
Cardiac Monitoring: Helps to detect and manage heart issues early.
-
Multidisciplinary Approach: Coordinated care involving neurologists, physiotherapists, cardiologists, pulmonologists and rehabilitation specialists.
Common Medications Used to Treat Muscular Dystrophy
There is no single medicine that treats all forms of muscular dystrophy. Medicines are mainly used to slow muscle weakness in certain types, manage complications and protect heart function.
Common medications used to treat muscular dystrophy are:
-
Prednisolone/Prednisone: These corticosteroids may help maintain muscle strength and slow functional decline in Duchenne muscular dystrophy (DMD).
-
Deflazacort: This corticosteroid is commonly used in DMD to help preserve muscle strength and delay loss of mobility.
-
Vamorolone: This newer corticosteroid may be used for DMD to improve or maintain muscle function while potentially reducing some steroid-related side effects.
-
Enalapril and Lisinopril: These ACE inhibitors may be prescribed when muscular dystrophy affects the heart, helping reduce strain on the heart muscle.
-
Carvedilol: This beta blocker may be added to help manage cardiomyopathy or other heart problems associated with some forms of muscular dystrophy.
-
Eteplirsen, Golodirsen, Viltolarsen and Casimersen: These exon-skipping medicines are used only in selected patients with DMD who have specific genetic mutations suitable for the respective therapy.
-
Calcium and Vitamin D: Supplements may be recommended to support bone health, particularly in patients receiving long-term corticosteroid treatment.
Note: Treatment depends on the specific type of muscular dystrophy and the patient's genetic findings, symptoms and complications. Some mutation-specific medicines are available only in certain countries or specialist centres, so a neuromuscular specialist should plan treatment.
Living with Muscular Dystrophy in India: Daily Challenges and Caregiving
Living with muscular dystrophy may gradually affect mobility, independence, education, work and everyday activities. Some patients also require long-term physiotherapy, mobility aids and regular heart or respiratory monitoring, depending on the type and severity of the condition.
Some of the challenges and critical care points for muscular dystrophy patients include:
-
Challenges
- Reduced Mobility: Progressive muscle weakness may make walking, climbing stairs, standing or changing positions increasingly difficult.
- Fatigue and Physical Limitations: Muscle weakness can make routine activities such as dressing, bathing, writing or travelling more tiring.
- Loss of Independence: Some patients may gradually need walking aids, wheelchairs or assistance with personal care.
- School and Work Difficulties: Mobility limitations, frequent appointments and fatigue may affect education, employment and social participation.
-
Caregiving and Patient Safety
- Mobility Support: Caregivers may help with transfers, walking aids, wheelchairs and home adaptations to reduce falls and maintain independence.
- Regular Physiotherapy: Stretching and physiotherapy can help maintain movement and reduce joint stiffness or contractures.
- Heart and Breathing Monitoring: Regular cardiac and respiratory assessments are important in forms of muscular dystrophy that affect these muscles.
- Emotional Support: Family support, counselling and social interaction can help patients cope with increasing dependence and changes in daily life.
-
Expenses
- Specialist Care: Regular visits to neurologists, cardiologists, physiotherapists and other specialists may create recurring expenses.
- Mobility and Support Equipment: Wheelchairs, braces, orthotic devices and home modifications may add to long-term costs.
- Medicines and Monitoring: Steroids, cardiac medicines, blood tests and heart or lung assessments may require ongoing spending.
- Rehabilitation and Caregiving: Physiotherapy, respiratory care and increasing assistance with daily activities may contribute substantially to the overall financial burden.
What is the Prognosis for Muscular Dystrophy?
The prognosis for muscular dystrophy varies widely depending on the type, age of onset and severity of muscle weakness. Some forms progress slowly and allow relatively independent living for many years, while others may cause significant mobility, heart or breathing problems. Treatment, physiotherapy and regular cardiac and respiratory care can help manage complications and maintain quality of life.
How to Prevent Muscular Dystrophy?
Inherited or spontaneous genetic changes usually cause muscular dystrophy, so it cannot generally be prevented. However, families with a history of muscular dystrophy can take the following steps to understand and manage the risk:
-
Genetic Counselling: Couples with a family history of muscular dystrophy can discuss inheritance patterns and the likelihood of passing the condition to a child.
-
Carrier Testing:Genetic tests can be conducted to identify whether a person carries a disease-causing gene linked to certain types, such as Duchenne or Becker muscular dystrophy.
-
Prenatal Testing: Tests during pregnancy may detect specific genetic changes when a familial mutation is already known.
-
Preimplantation Genetic Testing: Some couples may consider IVF with genetic testing of embryos to reduce the chance of passing on a known inherited form of muscular dystrophy.
Note: These measures cannot prevent spontaneous genetic mutations, but they can help families make informed reproductive decisions.
Muscular Dystrophy Treatment Cost in India
The costs associated with muscular dystrophy treatment depend on the kind of disease, its severity, the approach to treatment and the need for rehabilitation.
An approximation of the muscular dystrophy treatment cost in India is given below:
| Treatment | Appointment Cost (India) |
| Neurologist consultation | ₹800 - ₹2,500 |
| Genetic testing | ₹10,000 - ₹40,000 |
| Creatine kinase (CK) test | ₹500 - ₹1,500 |
| MRI (if required) | ₹5,000 - ₹18,000 |
| Electromyography (EMG) | ₹2,000 - ₹6,000 |
| Physiotherapy (per session) | ₹500 - ₹2,000 per session |
| Deflazacort | ₹100 - ₹500 |
| Newer Disease-Specific DMD Therapies | Approximately ₹5 - ₹10 crore per year |
Note: Costs could differ depending on hospitals, towns, the level of disease and the treatment needed.
Does Health Insurance Cover Muscular Dystrophy?
Yes. Health insurance in India may cover muscular dystrophy when the policy permits coverage for genetic disorders and the applicable terms and conditions are met. Eligible in-patient hospitalisation expenses may include room rent, ICU charges, surgeon and specialist fees, diagnostic tests, medicines and other medically necessary expenses incurred during an active hospital admission. Some policies may also cover rehabilitation or physiotherapy, depending on the insurer and plan.
Muscular dystrophy is also covered under a critical illness insurance plan. The insurer provides a lump-sum payout that can be used towards treatment costs and other financial needs arising from the condition. However, you have to complete a waiting period of up to 90 days and a survival period of up to 30 days.
Since benefits vary between insurers, patients should review the policy carefully to understand what is covered and any applicable limits.
How Much Health Insurance Coverage Is Needed for Muscular Dystrophy Treatment?
For patients receiving standard treatment, ₹10 lakh - ₹25 lakh of coverage may provide a practical buffer for hospitalisation, investigations and other covered medical care.
Patients with heart or respiratory complications, repeated hospitalisations or greater supportive-care needs may consider ₹25 lakh - ₹50 lakh or more in coverage. Those planning to pursue newer disease-specific therapies for Duchenne muscular dystrophy may face costs of approximately ₹5 - ₹10 crore per year, in addition to supportive care.
Frequently Asked Questions (FAQs)
-
Q1. What is the first sign of muscular dystrophy?
Ans: Early signs of muscular dystrophy include muscle weakness, frequent falls or difficulty running, climbing stairs or getting up from the floor. -
Q2. Can muscular dystrophy be cured?
Ans: No, there is no cure for muscular dystrophy yet, but treatments are available that can manage symptoms, delay progression and help people stay independent for longer. -
Q3. Is muscular dystrophy inherited from parents?
Ans: Many types of muscular dystrophy are inherited, but some result from new genetic changes without a family history.
-
References
-
https://www.ncbi.nlm.nih.gov/books/NBK1119
-
https://www.ninds.nih.gov/health-information/disorders/muscular-dystrophy
-
https://link.springer.com/article/10.1186/s13018-022-02996-8
-
https://www.nature.com/articles/s41572-021-00248-3
-
